Tenaya治疗学击败Q1收入估计数,中午以0.51美元交易,目标价格为17.33美元。 Tenaya Therapeutics beat Q1 earnings estimates, trading midday at $0.51 with a $17.33 target price.

泰纳亚治疗公司的季度收益为每股0.28美元, 超过预期的0.04美元. Tenaya Therapeutics reported quarterly earnings of ($0.28) per share, beating estimates by $0.04. 中午51美元的股票交易额,1 700万股票交易额。 Shares traded at $0.51 midday, with 17 million shares traded. 生物技术公司的重点是通过基因编辑和细胞再生进行心脏病治疗,其平均“Buy”评级为“Buy”,目标价格为17.33美元。 The biotech company, focusing on heart disease therapies through gene editing and cellular regeneration, has an average "Buy" rating with a target price of $17.33.